<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468221</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient.</ArticleTitle><Pagination><StartPage>25790</StartPage><MedlinePgn>25790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-75241-3</ELocationID><Abstract><AbstractText>The emergence of the SARS-CoV-2 virus led to a global pandemic, prompting extensive research efforts to understand its molecular biology, transmission dynamics, and pathogenesis. Recombination events have been increasingly recognized as significant contributor to the virus's diversity and evolution, potentially leading to the emergence of novel strains with altered biological properties. Indeed, recombinant lineages such as the XBB variant and its descendants have subsequently dominated globally. Therefore, continued surveillance and monitoring of viral genome diversity are crucial to identify and understand the emergence and spread of novel strains. Through routine genomic surveillance of SARS-CoV-2 cases in Norway, we discovered a SARS-CoV-2 recombination event in a long-term infected immunocompromised COVID-19 (coronavirus disease) patient. A deeper investigation showed several recombination events between two distinct lineages of the virus, namely AY.98.1 and BA.5, that resulted in a single novel recombinant viral strain with a unique genetic signature. Our data is consistent with the presence of several concomitant recombinants in the patient, suggesting that these events occur frequently in vivo. This study underscores the importance of continued tracking of viral diversity and the potential impact of recombination events on the evolution of the SARS-CoV-2 virus.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Bacteriology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bråte</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fossum</LastName><ForeName>Even</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohringer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moen</LastName><ForeName>Line V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hungnes</LastName><ForeName>Olav</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fjære</LastName><ForeName>Olav</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Section for Infectious Diseases, Department of Internal Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaragkoulias</LastName><ForeName>Kyriakos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section for Medical Microbiology, Department of Laboratory Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragstad</LastName><ForeName>Karoline</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway. iggl@fhi.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delta</Keyword><Keyword MajorTopicYN="N">Immunocompromised</Keyword><Keyword MajorTopicYN="N">In-patient recombination event</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Recombinant</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468221</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-75241-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-75241-3</ArticleId></ArticleIdList><ReferenceList><Title /><Reference><Citation>World Health Organization. COVID-19 weekly epidemiological update, edition 115, 26 October 2022. (2022). https://apps.who.int/iris/handle/10665/363853 .</Citation></Reference><Reference><Citation>World Bank. World development report 2022: Finance for an equitable recovery. (2022). https://doi.org/10.1596/978-1-4648-1730-4 .</Citation></Reference><Reference><Citation>OECD. Risks that matter 2020: The long reach of COVID-19. (2021). https://read.oecd-ilibrary.org/view/?ref=1092_1092352-pnu0599ga4&amp;title=Risks-that-matter-2020-the-long-reach-of-COVID-19 .</Citation></Reference><Reference><Citation>Meyerowitz, E. A., Richterman, A., Gandhi, R. T. &amp; Sax, P. E. Transmission of SARS-CoV-2: A review of viral, host, and environmental factors. Ann. Intern. Med. 174(1), 69–79 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5008</ArticleId><ArticleId IdType="pubmed">32941052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798), 270–273 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId><ArticleId IdType="pmc">7095418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley, K. &amp; Evans, D. J. Mechanisms and consequences of positive-strand RNA virus recombination. J. Gen. Virol. 99(10), 1345–1356 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001142</ArticleId><ArticleId IdType="pubmed">30156526</ArticleId></ArticleIdList></Reference><Reference><Citation>Focosi, D. &amp; Maggi, F. Recombination in coronaviruses, with a focus on SARS-CoV-2. Viruses 14(6), 1239 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061239</ArticleId><ArticleId IdType="pubmed">35746710</ArticleId><ArticleId IdType="pmc">9228924</ArticleId></ArticleIdList></Reference><Reference><Citation>Burel, E. et al. Sequential appearance and isolation of a SARS-CoV-2 recombinant between two major SARS-CoV-2 variants in a chronically infected immunocompromised patient. Viruses 14(6), 1266 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061266</ArticleId><ArticleId IdType="pubmed">35746737</ArticleId><ArticleId IdType="pmc">9227898</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekizuka, T. et al. Recombination between SARS-CoV-2 Omicron BA.1 and BA.2 variants identified in a traveller from Nepal at the airport quarantine facility in Japan. J. Travel Med. https://doi.org/10.1093/jtm/taac051 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taac051</ArticleId><ArticleId IdType="pubmed">35442444</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums, D. V. Editorial: The XBB.1.5 ('Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread. Med. Sci. Monit. 29, e939580 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36722047</ArticleId><ArticleId IdType="pmc">9901170</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. data.who.int, WHO Coronavirus (COVID-19) dashboard &gt; About [Dashboard]. (2023). https://data.who.int/dashboards/covid19/about .</Citation></Reference><Reference><Citation>Harari, S. et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat. Med. 28, 1501–1508 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01882-4</ArticleId><ArticleId IdType="pubmed">35725921</ArticleId><ArticleId IdType="pmc">9307477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, P., de Vries, A. C., Kamar, N., Peppelenbosch, M. P. &amp; Pan, Q. Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations. Lancet Microbe 3(5), e325–e326 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00061-1</ArticleId><ArticleId IdType="pubmed">35309711</ArticleId><ArticleId IdType="pmc">8923675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zannoli, S. et al. SARS-CoV-2 coinfection in immunocompromised host leads to the generation of recombinant strain. Int. J. Infect. Dis. 131, 65–70 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.03.014</ArticleId><ArticleId IdType="pubmed">36924839</ArticleId><ArticleId IdType="pmc">10014127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, S., Zhou, Y., Chen, Y. &amp; Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17), i884–i890 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty560</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId><ArticleId IdType="pmc">6129281</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead, B. &amp; Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9(4), 357–359 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId><ArticleId IdType="pmc">3322381</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience https://doi.org/10.1093/gigascience/giab008 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giab008</ArticleId><ArticleId IdType="pubmed">33594436</ArticleId><ArticleId IdType="pmc">7931820</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20(1), 8 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1618-7</ArticleId><ArticleId IdType="pubmed">30621750</ArticleId><ArticleId IdType="pmc">6325816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chollet, F. et al. Keras. (2015). https://keras.io .</Citation></Reference><Reference><Citation>Abadi, M. et al. TensorFlow: Large-scale machine learning on heterogeneous systems. (2015). https://tensorflow.org .</Citation></Reference><Reference><Citation>O’Toole, A. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. https://doi.org/10.1093/ve/veab064 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId><ArticleId IdType="pmc">8344591</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov, I., Roemer, C., Hodcroft, E. &amp; Neher, R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 6, 3773 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, Y. et al. covSampler: A subsampling method with balanced genetic diversity for large-scale SARS-CoV-2 genome data sets. Virus Evol. https://doi.org/10.1093/ve/veac071 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac071</ArticleId><ArticleId IdType="pubmed">36533145</ArticleId><ArticleId IdType="pmc">9671156</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. A language and environment for statistical computing. (2022). https://www.R-project.org .</Citation></Reference><Reference><Citation>Wickham, H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. (2016) https://ggplot2.tidyverse.orghttps://ggplot2.tidyverse.org .</Citation></Reference><Reference><Citation>Bloom, J. D. &amp; Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol. https://doi.org/10.1093/ve/vead055 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vead055</ArticleId><ArticleId IdType="pubmed">39129757</ArticleId><ArticleId IdType="pmc">10868542</ArticleId></ArticleIdList></Reference><Reference><Citation>Strelkowa, N. &amp; Lässig, M. Clonal interference in the evolution of influenza. Genetics 192(2), 671–682 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.112.143396</ArticleId><ArticleId IdType="pubmed">22851649</ArticleId><ArticleId IdType="pmc">3454888</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>